ロード中...
The Time Has Come for Targeted Therapies for AML: Lights and Shadows
Acute myeloid leukemia (AML) is a complex disease characterized by genetic and clinical heterogeneity and high mortality. After 40 years during which the standard of care for patients evolved very little, the therapeutic landscape has recently seen rapid changes, with the approval of eight new drugs...
保存先:
| 出版年: | Oncol Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359996/ https://ncbi.nlm.nih.gov/pubmed/32700072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-019-00108-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|